Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Inclusion Criteria: * Diagnosis of Atopic Dermatitis which is rated moderate, severe or very severe using the Investigator's Global Atopic Dermatitis Assessment involving a minimum of 5% of the body's surface area * If female, and of childbearing potential, patient has a negative pregnancy test and agrees to practice effective birth control during the study Exclusion Criteria: * Patient has a skin disorder other than Atopic Dermatitis in the areas to be treated * Patient has extensive scarring or pigmented lesions in the areas to be treated that would interfere with rating of efficacy parameters * Patient has clinically infected Atopic Dermatitis at baseline * Patient is likely to require systemic corticosteroids, or the patient is likely to require intranasal or inhaled corticosteroids for an off-label indication or at higher doses than the maximum labeled dosing for the drug * Patient has a known hypersensitivity to macrolides or any excipient of either study medication * Patient has a chronic condition which is either not stable or not well controlled * Patient is pregnant or breast feeding an infant